Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Pulmonary Embolism after Acute Spinal Cord Injury and COVID-19: A Case Report

Pulmonary Embolism after Acute Spinal Cord Injury and COVID-19: A Case Report

American Journal of Physical Medicine & Rehabilitation, 2020 · DOI: 10.1097/PHM.0000000000001578 · Published: January 1, 2020

Spinal Cord InjuryCOVID-19Rehabilitation

Simple Explanation

COVID-19 is known for causing lung problems, but it can also make the blood more likely to clot. People with spinal cord injuries already have a higher risk of blood clots. This case report describes a patient who had both a spinal cord injury and COVID-19 and developed blood clots in his legs and lungs despite being given medication to prevent them. The patient in this report was found to have COVID-19 incidentally and did not have significant respiratory symptoms. He developed extensive blood clots in his legs despite preventative treatment and then developed pulmonary emboli even after starting therapeutic anticoagulation. This case shows that doctors need to be extra careful when screening and treating blood clots in patients who have both a spinal cord injury and COVID-19.

Study Duration
Not specified
Participants
One 48-year-old male
Evidence Level
Level 4: Case Report

Key Findings

  • 1
    The patient developed extensive bilateral lower extremity deep vein thrombosis (DVT) despite chemoprophylaxis.
  • 2
    Therapeutic anticoagulation was initiated, yet several days later he developed pleuritic chest pain, and a CT scan revealed bilateral pulmonary emboli.
  • 3
    The patient was PCR positive for SARS-CoV-2 virus, both at an outside hospital and at a tertiary hospital, without clinically apparent COVID-19 symptoms.

Research Summary

This case report highlights the need for increased vigilance in screening and treatment for VTE in high-risk patients, such as those with SCI and concurrent COVID-19. The patient developed extensive bilateral lower extremity DVT despite chemoprophylaxis and later developed bilateral pulmonary emboli despite therapeutic anticoagulation. The case underscores the increased VTE risk COVID-19 coagulopathy confers in acute SCI.

Practical Implications

Increased VTE Vigilance

Clinicians should have elevated vigilance in regards to screening and treatment for VTE in high-risk patients, such as SCI with a concurrent diagnosis of COVID-19.

Aggressive Management

Concurrent COVID-19 diagnosis in already high-risk VTE populations might require more aggressive management or interventions.

Prophylactic Anticoagulation

Prophylactic anticoagulation has been suggested for all hospitalized COVID-19 patients without contraindications.

Study Limitations

  • 1
    Single case report limits generalizability
  • 2
    Undocumented and uninsured status presented social challenges
  • 3
    Data is sparse regarding therapeutic effectiveness of direct oral anticoagulants in COVID-19 for VTE prevention

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury